InspireMD (NSPR) Gross Margin Growth (3y) (2013 - 2025)
InspireMD (NSPR) Gross Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -324.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 56.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 311.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -164.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | 1,817.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,817.00 |
| Sep 30, 2025 | 867.00 |
| Jun 30, 2025 | -1,055.00 |
| Mar 31, 2025 | 878.00 |
| Dec 31, 2024 | 276.00 |
| Sep 30, 2024 | 1,428.00 |
| Jun 30, 2024 | -621.00 |
| Mar 31, 2024 | 879.00 |
| Dec 31, 2023 | 27,551.00 |
| Sep 30, 2023 | -226.00 |
| Jun 30, 2023 | 6,811.00 |
| Mar 31, 2023 | 157.00 |
| Dec 31, 2022 | -627.00 |
| Sep 30, 2022 | 1,194.00 |
| Jun 30, 2022 | -449.00 |
| Mar 31, 2022 | 2,790.00 |
| Dec 31, 2021 | -631.00 |
| Sep 30, 2021 | -1,716.00 |
| Jun 30, 2021 | -238.00 |
| Mar 31, 2021 | -1,856.00 |